Display options
Share it on

Mov Disord Clin Pract. 2019 Dec 11;7(2):129-139. doi: 10.1002/mdc3.12874. eCollection 2020 Feb.

Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic Review.

Movement disorders clinical practice

Raquel Bouça-Machado, Gonçalo S Duarte, Maria Patriarca, Ana Castro Caldas, Joana Alarcão, Ricardo M Fernandes, Tiago A Mestre, Ricardo Matias, Joaquim J Ferreira

Affiliations

  1. Instituto de Medicina Molecular, Faculdade de Medicina Universidade de Lisboa Lisbon Portugal.
  2. CNS-Campus Neurológico Sénior Torres Vedras Portugal.
  3. Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina Universidade de Lisboa Lisbon Portugal.
  4. Center for Evidence-Based Medicine, Faculdade de Medicina Universidade de Lisboa Lisbon Portugal.
  5. Department of Pediatrics Santa Maria Hospital Lisbon Portugal.
  6. Parkinson's disease and Movement Disorders Center, Division of Neurology, Department of Medicine, The Ottawa Hospital Research Institute University of Ottawa Brain and Research Institute Ottawa Ontario Canada.
  7. Champalimaud Research and Clinical Centre Champalimaud Centre for the Unknown Lisbon Portugal.
  8. Human Movement Analysis Lab Escola Superior Saúde-Instituto Politécnico de Setúbal Setúbal Portugal.

PMID: 32071930 PMCID: PMC7011644 DOI: 10.1002/mdc3.12874

Abstract

BACKGROUND: Functional mobility (FM) is a person's ability to move to accomplish activities of daily living; it bridges the concepts of mobility and functional ability. There is frequently a loss of FM in Parkinson's disease (PD). Several instruments have been used to assess this concept in PD; however, there is no consensus on which are the most appropriate.

OBJECTIVE: We aimed to identify and critically appraise which measurement instruments have been used to assess FM.

METHODS: A systematic review was conducted using the databases CENTRAL, MEDLINE, Embase, and PEDro from their inception to January 2019 to identify all observational and experimental studies conducted in PD or atypical parkinsonism that included an FM assessment. Two reviewers independently screened citations, extracted data, and assessed clinimetric properties.

RESULTS: We included 95 studies that assessed FM in PD. Fifty-five (57.9%) studies mentioned FM in the article, and 39 (41.1%) specified the measurement tools used to evaluate FM. FM was the primary outcome in 12 (12.6%) studies. The Timed Up and Go test was the most frequently used measurement tool. Only one study presented a definition of FM. Several overlapping terms were used, the most common being mobility.

CONCLUSION: Several studies reported the use of FM measurement tools in PD, though with frequent misconceptions, an inadequate context of use, or suboptimal assessment. We propose the establishment of the concept of FM applied to PD, followed by the adequate clinimetric validation of existing measurement tools to provide a comprehensive and reliable evaluation of FM in PD.

© 2019 International Parkinson and Movement Disorder Society.

Keywords: Parkinson's disease; functional mobility; measurement instruments; outcome measures; systematic review

References

  1. PLoS One. 2018 Aug 22;13(8):e0201035 - PubMed
  2. Phys Ther. 2000 Nov;80(11):1087-96 - PubMed
  3. Mov Disord. 2010 Jun 15;25(8):1012-8 - PubMed
  4. J Neurol Phys Ther. 2011 Jun;35(2):90-7 - PubMed
  5. Gait Posture. 2014 Feb;39(2):784-8 - PubMed
  6. BMC Med. 2016 Dec 22;14(1):215 - PubMed
  7. Parkinsonism Relat Disord. 2012 Feb;18(2):149-54 - PubMed
  8. Phys Ther. 1997 Jan;77(1):19-27 - PubMed
  9. Can J Public Health. 1992 Jul-Aug;83 Suppl 2:S7-11 - PubMed
  10. J Parkinsons Dis. 2018;8(1):121-130 - PubMed
  11. Dev Med Child Neurol. 2012 Jul;54(7):596-605 - PubMed
  12. Clin Rehabil. 2010 Sep;24(9):831-42 - PubMed
  13. Phys Ther. 2000 Sep;80(9):896-903 - PubMed
  14. Parkinsonism Relat Disord. 2019 Aug;65:13-19 - PubMed
  15. J Am Geriatr Soc. 1991 Feb;39(2):142-8 - PubMed
  16. Phys Ther. 2001 Feb;81(2):810-8 - PubMed
  17. Parkinsonism Relat Disord. 2009 May;15(4):263-9 - PubMed
  18. Physiother Can. 2016;68(4):398-407 - PubMed
  19. Mov Disord. 2003 Jul;18(7):738-50 - PubMed
  20. Trials. 2016 Sep 13;17(1):449 - PubMed
  21. Clin Interv Aging. 2010 Aug 09;5:181-5 - PubMed
  22. Phys Ther. 2014 Feb;94(2):230-9 - PubMed
  23. Can Med Assoc J. 1985 Apr 15;132(8):919-23 - PubMed
  24. Best Pract Res Clin Endocrinol Metab. 2013 Apr;27(2):129-37 - PubMed
  25. Mov Disord. 2008 Nov 15;23(15):2129-70 - PubMed
  26. Dev Med Child Neurol. 2007 Aug;49(8):603-7 - PubMed
  27. Mov Disord. 2011 Oct;26(12):2169-75 - PubMed
  28. Brain Inj. 2004 Oct;18(10):1041-8 - PubMed
  29. Mov Disord. 2013 Nov;28(13):1793-800 - PubMed
  30. Arch Phys Med Rehabil. 2005 Apr;86(4):789-92 - PubMed
  31. Gerontologist. 2013 Apr;53(2):255-67 - PubMed
  32. Int Rev Neurobiol. 2017;132:129-182 - PubMed
  33. Phys Ther. 2008 Jun;88(6):733-46 - PubMed
  34. J Rehabil Med. 2010 Apr;42(4):323-31 - PubMed
  35. Eur J Phys Rehabil Med. 2017 Oct;53(5):664-675 - PubMed
  36. Arch Phys Med Rehabil. 2011 Sep;92(9):1431-6 - PubMed
  37. J Gerontol. 1990 Nov;45(6):M192-7 - PubMed
  38. J Aging Health. 2012 Aug;24(5):863-78 - PubMed
  39. Mov Disord. 2016 Sep;31(9):1342-55 - PubMed
  40. Percept Mot Skills. 1995 Feb;80(1):163-6 - PubMed
  41. Curr Dev Disord Rep. 2018;5(1):26-33 - PubMed

Publication Types